Evoke Pharma News - EVOK

Company Name	Stock Ticker Symbol	Market	Type
Evoke Pharma Inc	EVOK	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0192	4.01%	0.498	10:08:32

Open Price	Low Price	High Price	Close Price	Prev Close
0.498	0.498	0.498		0.4788

more quote information »

Recent News

Date	Time	Source	Heading
4/17/2024	08:30	GLOBE	Evoke Pharma to Host Virtual Key Opinion Leader (KOL)..
3/21/2024	16:15	GLOBE	Evoke Pharma Announces Senior Leadership Transition with..
3/14/2024	16:05	GLOBE	Evoke Pharma Reports Fourth Quarter and Full Year 2023..
3/07/2024	16:10	GLOBE	Evoke Pharma to Report Fourth Quarter and Full Year 2023..
2/23/2024	16:15	EDGAR2	Form 8-K - Current report
2/20/2024	16:38	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/14/2024	09:00	EDGAR2	Form 8-K - Current report
2/14/2024	07:30	GLOBE	Evoke Pharma Announces Closing of $7.5 Million Public..
2/09/2024	17:15	EDGAR2	Form 8-K - Current report
2/09/2024	17:14	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
2/09/2024	07:30	GLOBE	Evoke Pharma Announces Pricing of Underwritten Public..
2/09/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2/08/2024	06:50	EDGAR2	Form S-1/A - General form for registration of securities..
1/10/2024	21:38	EDGAR2	Form S-1/A - General form for registration of securities..
1/04/2024	16:30	EDGAR2	Form S-1/A - General form for registration of securities..
12/19/2023	08:30	EDGAR2	Form S-1/A - General form for registration of securities..
12/15/2023	16:30	EDGAR2	Form S-1/A - General form for registration of securities..
11/29/2023	09:00	EDGAR2	Form 8-K - Current report
11/27/2023	16:30	EDGAR2	Form 8-K - Current report
11/27/2023	08:30	GLOBE	Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI..
11/22/2023	16:15	EDGAR2	Form 8-K - Current report
11/14/2023	08:30	GLOBE	United States Patent and Trademark Office (USPTO) Grants..
11/09/2023	16:30	EDGAR2	Form S-1 - General form for registration of securities under..
11/09/2023	09:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	09:00	EDGAR2	Form 8-K - Current report
11/09/2023	08:30	GLOBE	Evoke Pharma Reports Third Quarter 2023 Financial Results
11/01/2023	08:30	EDGAR2	Form 8-K - Current report
10/31/2023	08:30	GLOBE	Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data..
10/18/2023	08:30	GLOBE	Evoke Pharma’s Abstract Entitled “Superiority of Nasal Spray..
10/12/2023	16:30	EDGAR2	Form 8-K - Current report
9/14/2023	08:30	GLOBE	Evoke Pharma Receives Notice of Allowance from USPTO for..
8/11/2023	09:01	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/10/2023	09:03	EDGAR2	Form 8-K - Current report
8/10/2023	09:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	08:30	GLOBE	Evoke Pharma Reports Second Quarter 2023 Financial Results
8/07/2023	08:30	GLOBE	Evoke Pharma and EVERSANA Announce Abstract Acceptance at..
7/25/2023	08:30	GLOBE	Evoke Pharma and EVERSANA Announce Abstract Selection for..
7/21/2023	09:00	EDGAR2	Form 8-K - Current report
6/14/2023	08:30	GLOBE	Evoke Pharma to Host First Key Opinion Leader Webinar on..
5/15/2023	16:05	GLOBE	Evoke Pharma Reports First Quarter 2023 Financial Results
5/09/2023	07:00	GLOBE	Real-World Data Presented by Evoke Pharma and EVERSANA at..
5/04/2023	08:30	GLOBE	Evoke Pharma’s Real-World Healthcare Utilization Data..
5/01/2023	08:30	GLOBE	New GIMOTI Patent Listed in FDA Orange Book
4/20/2023	08:30	GLOBE	United States Patent and Trademark Office (USPTO) Grants..